Results for “aveo”

Entry Author Date Location
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News 10/01/10 Boston
Merck Ends AVEO Collaboration 09/30/10 Boston
PerkinElmer Sells Unit for $500M, Aveo Stock Climbs, Pfizer Buys FoldRx, & More Boston-Area Life Sciences News 09/03/10 Boston
Aveo Pharma Stock Jumps 40 Percent in A Week, CEO Notes Progress in Pivotal Kidney Cancer Trial 08/31/10 Boston
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News 03/17/10 Boston
Aveo Pharmaceuticals Goes Public at $9, Falls Short of Hoped-For Range 03/11/10 Boston
Luminus Devices Nabs $19M, Aveo Sets IPO Range, Thermo Fisher Scientific Reportedly Makes $6 B Move on Millipore, & More Boston-Area Deals News 02/24/10 Boston
Aveo Sets IPO Price Range at $13-$15 a Share 02/23/10 Boston
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News 12/23/09 Boston
Aveo Aims for $86M Debut, Exagrid Snags $16M, PatientKeeper Adds $13M, & More Boston-Area Deals News 12/18/09 Boston
Aveo Pharmaceuticals Eyes $86.3M IPO 12/17/09 Boston
Aveo Nabs $20M From Extended Deal with OSI Pharma 07/21/09 Boston
Aveo Pieces Together a Plan to Rival Big Boys of Cancer Drug World 06/29/09 Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News 06/03/09 Boston
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings 06/01/09 Boston
Aveo Kidney Cancer Drug, Challenging Pfizer and Bayer, Passes Important Test 05/29/09 Boston
Aveo Pharmaceuticals, Inc. Lands $30,000,000 New Financing 04/10/09 Boston
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News 03/25/09 Boston
Aveo and Biogen in Antibody Partnership 03/24/09 Boston
Aveo Pharmaceuticals, Inc. Receives $5,499,600 New Financing 12/31/07 Boston
Riding the Biomarker Wave: Aveo Snags Eli Lilly Deal 12/05/07 Boston
Aveo’s Better Mousetraps for Cancer Drugs 06/29/07 Boston
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
Page 2 of 5 « previous page · next page »